Meng Wang

Meng works as Real-World Evidence Excellence Lead at Bristol-Myers Squibb China since Feb 2019. She leads cross-functional team in developing product’s value and evidence generation strategy, and implements strategic Real-World evidence generation plan and executes RWD studies in collaboration with matrix teams. Prior to this, she was Outcomes Research lead at BMS UK from Feb 2016 – Jan 2019, where timely, robust and impactful RWE was delivered in support of value proposition of BMS medicines. She holds a PhD degree from Imperial College London in environmental engineering and MSc from Cranfield University in Chemical engineering.